240
Participants
Start Date
April 3, 2017
Primary Completion Date
February 3, 2020
Study Completion Date
March 4, 2020
Remaxol®
Solution for intravenous infusions, containing succinate, methionine, inosine, and nicotinamide in 400 ml glass bottle
Ringer's Solution
Solution for intravenous infusion, 400 or 800 ml
GBUZ 'Bryansk City Hospital #1', Bryansk
Regional Clinical Hospital of Emergency Care n.a.M.A.Podgorbunsky, Kemerovo
KBUZ 'Regional Clinical Hospital', Krasnoyarsk
OBUZ 'Kursy Regional Clinical Oncology Dispensary' of Kursky Regional Healthcare Department, Kursk
Moscow City Clinical Hospital #1 n.a.N.I.Pirogov, Moscow
Moscow City Clinical Hospital #29 n.a.N.A.Bauman, Moscow
Omsk Regional Clinical Oncology Center, Omsk
"GBUZ Penza Regional Clinical Hospital na N.N.Burdenko", Penza
City Clinical Hospital of Emergency Care, Ryazan
GBUZ 'Leningrad Regional Oncology Center', Saint Petersburg
GBUZ Leningrad Regional Clinical Hospital, Saint Petersburg
Hospital for War Veterans, Saint Petersburg
North-West State Medical University named after I.I. Mechnikov, Saint Petersburg
Saint-Petersburg I.I.Dzanelidze Research Institute of Emergency Medicine, Saint Petersburg
"SPb GBUZ City Hospital №26", Saint Petersburg
SPb GBUZ 'City Mariinskaya Hospital', Saint Petersburg
"OGAUZ Tomsk Regional Clinical Hospital", Tomsk
Siberian State Medical University, Tomsk
POLYSAN Scientific & Technological Pharmaceutical Company
INDUSTRY